Jiajun Ning, Ph.D., is a healthcare investment banking professional with experience in equity research across the biotech and pharmaceutical industries. Currently serving as an Investment Banking Associate at CITI since 2025, Jiajun previously worked as an Equity Research Analyst at Haitong International Securities Group Limited, where responsibilities included preparing research reports and maintaining financial models. Jiajun also interned at China Securities Co., Ltd and Hyfinity Investment, focusing on competitive landscape research and technical due diligence in the healthcare sector. Jiajun holds a Ph.D. in Biochemistry and Molecular Biology from The University of Hong Kong.
Location
Hong Kong, Hong Kong
This person is not in the org chart
This person is not in any teams
This person is not in any offices